Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1097 to 1146 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1097\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homolog of yeast maf1. [source:refseq;acc:nm\_032272]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6133.83\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6690.18\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0907\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1098\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 2. [source:refseq;acc:nm\_178865]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1099\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed protein 1 (transmembrane protein sbbi99). [source:swissprot;acc:q13530]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tumor differentially expressed 1 protein like. [source:swissprot;acc:q9nrx5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
d-3-phosphoglycerate dehydrogenase (ec 1.1.1.95) (3-pgdh). [source:swissprot;acc:o43175]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1102\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phenylalanyl-trna synthetase beta chain (ec 6.1.1.20) (phenylalanine-- trna ligase beta chain) (phers) (hspc173). [source:swissprot;acc:q9nsd9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5462.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5958.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09066\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1103\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ny-ren-62 antigen (fragment). [source:sptrembl;acc:q9y590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5843.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09062\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif2 (kinesin-2) (hk2). [source:swissprot;acc:o00139]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5359.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09054\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
synaptotagmin xii (sytxii). [source:swissprot;acc:q8iv01]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5460.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5954.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09049\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5489.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5986.63\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.09046\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1108\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rrp5 protein homolog (programmed cell death protein 11). [source:swissprot;acc:q14690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4846.16\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5283.08\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09016\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1109\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab3a interacting protein (rabin3)-like 1. [source:refseq;acc:nm\_013401]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6545.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7132.89\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08979\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1110\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadph:adrenodoxin oxidoreductase, mitochondrial precursor (ec 1.18.1.2) (adrenodoxin reductase) (ar) (ferredoxin-nadp(+) reductase). [source:swissprot;acc:p22570]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5947.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6481.56\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1111\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab3a interacting protein isoform alpha 1; rabin3; ssx2 interacting protein. [source:refseq;acc:nm\_022456]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6540.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7127.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08972\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1112\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative phosphoglycerate mutase 3 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13). [source:swissprot;acc:q8n0y7]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5910.54\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6440.58\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08968\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1113\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 1 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme b) (pgam-b) (bpg-dependent pgam 1). [source:swissprot;acc:p18669]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1114\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphoglycerate mutase 2 (ec 5.4.2.1) (ec 5.4.2.4) (ec 3.1.3.13) (phosphoglycerate mutase isozyme m) (pgam-m) (bpg-dependent pgam 2) (muscle-specific phosphoglycerate mutase). [source:swissprot;acc:p15259]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1115\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-methyltetrahydrofolate--homocysteine methyltransferase (ec 2.1.1.13) (methionine synthase, vitamin-b12 dependent) (ms). [source:swissprot;acc:q99707]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5795.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6314.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08957\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1116\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynactin complex 50 kda subunit (50 kda dynein-associated polypeptide) (dynamitin) (dctn-50) (dynactin 2). [source:swissprot;acc:q13561]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5322.16\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5798.38\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08948\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1117\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1118\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, heart/skeletal muscle isoform t1 (adp/atp translocase 1) (adenine nucleotide translocator 1) (ant 1). [source:swissprot;acc:p12235]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1119\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, fibroblast isoform (adp/atp translocase 2) (adenine nucleotide translocator 2) (ant 2). [source:swissprot;acc:p05141]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1120\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock factor binding protein 1. [source:swissprot;acc:o75506]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5915.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6443.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08932\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1121\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein nop5 (nucleolar protein 5) (nop58) (hspc120). [source:swissprot;acc:q9y2x3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4338.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4725.86\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08929\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1122\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
isocitrate dehydrogenase [nadp], mitochondrial precursor (ec 1.1.1.42) (oxalosuccinate decarboxylase) (idh) (nadp+-specific icdh) (idp) (icd-m). [source:swissprot;acc:p48735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7937.72\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8646.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08928\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1123\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
argininosuccinate lyase (ec 4.3.2.1) (arginosuccinase) (asal). [source:swissprot;acc:p04424]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5857.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6380.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08927\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1124\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 2 (esg2). [source:swissprot;acc:q04725]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6288.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6846.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08885\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1125\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin-like enhancer protein 1 (esg1). [source:swissprot;acc:q04724]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6287.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6845.28\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08879\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1126\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-6 subunit (karyopherin alpha-5 subunit). [source:swissprot;acc:o15131]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5792.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6305.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08867\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1127\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
yip1 interacting factor homolog; yip1p-interacting factor; putative rab5-interacting protein; putative transmembrane protein 54tmp. [source:refseq;acc:nm\_020470]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}&\multirow{15}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08864\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1128\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-3 subunit (k+ channel beta-3 subunit) (kv-beta-3). [source:swissprot;acc:o43448]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6303.94\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-1 subunit (k+ channel beta-1 subunit) (kv-beta-1). [source:swissprot;acc:q14722]\vspace{3pt}}&&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1130\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
similar to putative transmembrane protein; homolog of yeast golgi membrane protein yif1p (yip1p-interacting factor). [source:refseq;acc:nm\_033557]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1131\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 2 (ec 1.-.-.-) (afb1-ar 2). [source:swissprot;acc:o95154]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1132\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 3; lung alpha/beta hydrolase 3. [source:refseq;acc:nm\_138340]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1133\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
golgi membrane protein sb140; smooth muscle cell associated protein 5. [source:refseq;acc:nm\_030799]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1134\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha/beta hydrolase domain containing protein 1 isoform 2; lung alpha/beta hydrolase protein 1. [source:refseq;acc:nm\_152870]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1135\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial precursor (ec 1.2.1.27) (mmsdh). [source:swissprot;acc:q02252]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5790.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6303.95\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1136\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
10 kda heat shock protein, mitochondrial (hsp10) (10 kda chaperonin) (cpn10). [source:swissprot;acc:q04984]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6303.92\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1137\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rab acceptor 1 (prenylated); prenylated rab acceptor 1. [source:refseq;acc:nm\_006423]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1138\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligoribonuclease, mitochondrial precursor (ec 3.1.-.-) (small fragment nuclease) (cgi-114). [source:swissprot;acc:q9y3b8]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1139\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
choline o-acetyltransferase (ec 2.3.1.6) (choactase) (choline acetylase) (chat). [source:swissprot;acc:p28329]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5790.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6303.95\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1140\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-gated potassium channel beta-2 subunit (k+ channel beta-2 subunit) (kv-beta-2) (hkvbeta2). [source:swissprot;acc:q13303]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5790.65\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6303.93\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1141\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aflatoxin b1 aldehyde reductase 1 (ec 1.-.-.-) (afb1-ar 1) (aldoketoreductase 7). [source:swissprot;acc:o43488]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1142\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-1 subunit (karyopherin alpha-1 subunit) (srp1-beta) (rag cohort protein 2) (nucleoprotein interactor 1) (npi-1). [source:swissprot;acc:p52294]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5789.07\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6302.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0886\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1143\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein engrailed-2 (hu-en-2). [source:swissprot;acc:p19622]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6281.21\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6837.61\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.08858\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1144\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cpg binding protein (protein containing phd finger and cxxc domain 1). [source:swissprot;acc:q9p0u4]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1145\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s30. [source:swissprot;acc:q05472]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5893.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6416.07\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1146\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
activator of basal transcription 1; tata-binding protein-binding protein; basal transcriptional activator. [source:refseq;acc:nm\_013375]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6281.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6837.61\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/